Ewings sarcoma

Reading File
Finding Sources
Searching Images

Ewing sarcoma histology small round blue cells

This is a light microscopy image of a bone tumor biopsy stained with Hematoxylin and Eosin (H&E). The image demonstrates the classic small round blue cell morphology of Ewing sarcoma. The tumor is composed of uniform, small, primitive-appearing cells with scant pale eosinophilic or clear cytoplasm and rounded to oval nuclei with evenly dispersed chromatin and small or inconspicuous nucleoli. Cytoplasmic borders are indistinct, producing a syncytial appearance. Mitotic activity is variable and may be increased. Intracytoplasmic glycogen is common and can be highlighted with periodic acid–Schiff (PAS) staining; this feature supports the diagnosis of this entity. The tumor cell nests may arrange around delicate vasculature to form pseudorosettes; true Homer-Wright rosettes may be present in some cases. The stroma is a delicate vascular network; necrosis is frequent, appearing as large geographic areas or smaller foci. Together these features produce a dense, sheets-and-nests pattern with a high nuclear-to-cytoplasmic ratio typical of small round blue cell tumors. The image is diagnostic when integrated with immunohistochemical and molecular studies (e.g., CD99 positivity, EWSR1 rearrangement) but the morphology shown is highly characteristic of Ewing sarcoma. This histology is pathognomonic in the appropriate clinical context and is essential for prognosis and treatment planning.

This is a light microscopy image of a bone tumor biopsy stained with Hematoxylin and Eosin (H&E). The image demonstrates the classic small round blue cell morphology of Ewing sarcoma. The tumor is composed of uniform, small, primitive-appearing cells with scant pale eosinophilic or clear cytoplasm and rounded to oval nuclei with evenly dispersed chromatin and small or inconspicuous nucleoli. Cytoplasmic borders are indistinct, producing a syncytial appearance. Mitotic activity is variable and may be increased. Intracytoplasmic glycogen is common and can be highlighted with periodic acid–Schiff (PAS) staining; this feature supports the diagnosis of this entity. The tumor cell nests may arrange around delicate vasculature to form pseudorosettes; true Homer-Wright rosettes may be present in some cases. The stroma is a delicate vascular network; necrosis is frequent, appearing as large geographic areas or smaller foci. Together these features produce a dense, sheets-and-nests pattern with a high nuclear-to-cytoplasmic ratio typical of small round blue cell tumors. The image is diagnostic when integrated with immunohistochemical and molecular studies (e.g., CD99 positivity, EWSR1 rearrangement) but the morphology shown is highly characteristic of Ewing sarcoma. This histology is pathognomonic in the appropriate clinical context and is essential for prognosis and treatment planning.

Imaging modality: Histopathology using light microscopy of formalin-fixed, paraffin-embedded bone tissue stained with Hematoxylin and Eosin (H&E). The slide displays a skeletally derived lesion with features classic for Ewing sarcoma. At high cellular density, there are sheets of small round blue cells with scant cytoplasm and round to oval nuclei showing hyperchromasia and brisk mitotic activity. The tumor cells are arranged in uniform clusters, separated by delicate fibrous strands, creating a highly cellular, often undulating landscape. Areas of geographic necrosis are frequently seen within the tumor, producing pink, acellular zones that disrupt cohesive cell architecture. Cytoplasmic scantiness and high nuclear-to-cytoplasmic ratio are typical; occasional rosette-like formations (Homer-Wright) may be present but are not required for diagnosis. The overall histologic pattern corresponds to a high-grade small round blue cell neoplasm in bone. Although not shown in this image, CD99 membrane positivity is commonly observed in Ewing sarcoma and, together with molecular testing for EWSR1-FLI1 fusion (t(11;22)) or related rearrangements, strengthens the diagnosis. Clinically, this histology correlates with aggressive bone lesions in children and adolescents and has important differential considerations including lymphoma, rhabdomyosarcoma, neuroblastoma, and osteosarcoma. Correlation with radiology and immunohistochemistry is essential for definitive diagnosis and prognostic assessment in clinical practice overall.

Imaging modality: Histopathology using light microscopy of formalin-fixed, paraffin-embedded bone tissue stained with Hematoxylin and Eosin (H&E). The slide displays a skeletally derived lesion with features classic for Ewing sarcoma. At high cellular density, there are sheets of small round blue cells with scant cytoplasm and round to oval nuclei showing hyperchromasia and brisk mitotic activity. The tumor cells are arranged in uniform clusters, separated by delicate fibrous strands, creating a highly cellular, often undulating landscape. Areas of geographic necrosis are frequently seen within the tumor, producing pink, acellular zones that disrupt cohesive cell architecture. Cytoplasmic scantiness and high nuclear-to-cytoplasmic ratio are typical; occasional rosette-like formations (Homer-Wright) may be present but are not required for diagnosis. The overall histologic pattern corresponds to a high-grade small round blue cell neoplasm in bone. Although not shown in this image, CD99 membrane positivity is commonly observed in Ewing sarcoma and, together with molecular testing for EWSR1-FLI1 fusion (t(11;22)) or related rearrangements, strengthens the diagnosis. Clinically, this histology correlates with aggressive bone lesions in children and adolescents and has important differential considerations including lymphoma, rhabdomyosarcoma, neuroblastoma, and osteosarcoma. Correlation with radiology and immunohistochemistry is essential for definitive diagnosis and prognostic assessment in clinical practice overall.

This light-microscopy histology slide shows Desmoplastic small round cell tumor (DSRCT) morphology. Hematoxylin and eosin (H&E) staining reveals sharply demarcated nests and anastomosing trabeculae of small round blue cells with scant cytoplasm and hyperchromatic nuclei, embedded in a densely desmoplastic fibrous stroma. The tumor cells exhibit brisk mitotic activity and occasional rosette-like patterns. The desmoplastic background contains abundant collagen with prominent vascularity, contributing to the fibrous, hyalinized appearance. While not visible by this stain alone, typical immunophenotype includes coexpression of epithelial and mesenchymal markers (cytokeratins, EMA) and desmin in a dot-like perinuclear pattern; WT1 positivity supports the diagnosis. Molecular confirmation commonly shows EWS-WT1 fusion from t(11;22)(p13;q12). Clinically, DSRCT is an aggressive small round cell sarcoma arising primarily in the abdomen or pelvis with potential for peritoneal spread and multicentric involvement; prognosis is poor despite multimodal therapy. This image is valuable for educational purposes, illustrating the characteristic nest-desmoplastic matrix contrast and serving as a reference in differential diagnosis against Ewing sarcoma/PNET, neuroblastoma, and rhabdomyosarcoma. It underscores the need for ancillary studies to confirm diagnosis in pathology practice. This image emphasizes classic DSCRT morphology and the essential role of molecular testing in confirming the EWS-WT1 translocation. This makes it valuable for research and education.

This light-microscopy histology slide shows Desmoplastic small round cell tumor (DSRCT) morphology. Hematoxylin and eosin (H&E) staining reveals sharply demarcated nests and anastomosing trabeculae of small round blue cells with scant cytoplasm and hyperchromatic nuclei, embedded in a densely desmoplastic fibrous stroma. The tumor cells exhibit brisk mitotic activity and occasional rosette-like patterns. The desmoplastic background contains abundant collagen with prominent vascularity, contributing to the fibrous, hyalinized appearance. While not visible by this stain alone, typical immunophenotype includes coexpression of epithelial and mesenchymal markers (cytokeratins, EMA) and desmin in a dot-like perinuclear pattern; WT1 positivity supports the diagnosis. Molecular confirmation commonly shows EWS-WT1 fusion from t(11;22)(p13;q12). Clinically, DSRCT is an aggressive small round cell sarcoma arising primarily in the abdomen or pelvis with potential for peritoneal spread and multicentric involvement; prognosis is poor despite multimodal therapy. This image is valuable for educational purposes, illustrating the characteristic nest-desmoplastic matrix contrast and serving as a reference in differential diagnosis against Ewing sarcoma/PNET, neuroblastoma, and rhabdomyosarcoma. It underscores the need for ancillary studies to confirm diagnosis in pathology practice. This image emphasizes classic DSCRT morphology and the essential role of molecular testing in confirming the EWS-WT1 translocation. This makes it valuable for research and education.

This histopathology image represents a small round blue cell tumor of the renal pelvis, consistent with primitive neuroectodermal tumor (PNET)/Ewing family tumor. Acquired from a renal pelvis specimen showing invasion into the urothelial lining, the section is stained with hematoxylin and eosin and viewed under light microscopy at low to intermediate magnification. The tumor is organized in broad sheets of uniform, round cells with scant cytoplasm and hyperchromatic nuclei, yielding a classic high nuclear-to-cytoplasmic ratio. Mitotic figures are frequent and apoptotic activity may be evident; the surrounding renal parenchyma shows desmoplastic response and focal invasion of the mucosa, with the urothelium on the left preserved in outline. The lesion’s morphology mirrors other Ewing sarcoma family tumors and underlines the close morphologic and genetic kinship to EWSR1-associated neoplasms. Immunophenotyping (where performed) would typically show CD99 (MIC2) expression and may reveal EWSR1 gene rearrangement (e.g., EWSR1-FLI1) by molecular testing. Clinically, such tumors are aggressive and require multidisciplinary management. This image highlights the diagnostic significance of recognizing small round blue cell morphology in the renal pelvis, differentiating from Wilms tumor, lymphoma, rhabdomyosarcoma, and neuroblastoma, and underscores the role of histology complemented by molecular diagnostics for accurate classification and staging.

This histopathology image represents a small round blue cell tumor of the renal pelvis, consistent with primitive neuroectodermal tumor (PNET)/Ewing family tumor. Acquired from a renal pelvis specimen showing invasion into the urothelial lining, the section is stained with hematoxylin and eosin and viewed under light microscopy at low to intermediate magnification. The tumor is organized in broad sheets of uniform, round cells with scant cytoplasm and hyperchromatic nuclei, yielding a classic high nuclear-to-cytoplasmic ratio. Mitotic figures are frequent and apoptotic activity may be evident; the surrounding renal parenchyma shows desmoplastic response and focal invasion of the mucosa, with the urothelium on the left preserved in outline. The lesion’s morphology mirrors other Ewing sarcoma family tumors and underlines the close morphologic and genetic kinship to EWSR1-associated neoplasms. Immunophenotyping (where performed) would typically show CD99 (MIC2) expression and may reveal EWSR1 gene rearrangement (e.g., EWSR1-FLI1) by molecular testing. Clinically, such tumors are aggressive and require multidisciplinary management. This image highlights the diagnostic significance of recognizing small round blue cell morphology in the renal pelvis, differentiating from Wilms tumor, lymphoma, rhabdomyosarcoma, and neuroblastoma, and underscores the role of histology complemented by molecular diagnostics for accurate classification and staging.

Searching PubMed

"Ewing sarcoma"[MeSH Terms] AND treatment

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
I have comprehensive data from multiple authoritative textbooks. Let me now compile the full detailed answer.

Ewing Sarcoma

Overview

Ewing sarcoma is a highly malignant, small round blue cell tumor that arises primarily in bone, though 20% are extraskeletal (extraosseous Ewing sarcoma). It is the second most common primary bone sarcoma in children and young adults (after osteosarcoma), and the most common primary bone malignancy in patients under 10 years. Approximately 200 cases are diagnosed annually in the US. There is a slight male predominance, and the tumor is exceedingly rare in individuals of African descent.
  • Robbins & Kumar Basic Pathology, p. 786
  • Campbell's Operative Orthopaedics 15th Ed 2026, p. 1221

Epidemiology

FeatureDetail
Peak age5-25 years (80% under 20)
SexSlight male predominance
RacePredominantly White/European origin; exceedingly rare in Black individuals
Incidence<1 per 1 million per year
Annual US cases~200

Pathogenesis / Molecular Genetics

Nearly all (>90%) Ewing sarcomas carry a balanced translocation involving the EWSR1 gene on chromosome 22:
  • t(11;22)(q24;q12) - EWSR1-FLI1 fusion: ~85% of cases (most common)
  • t(21;22)(q22;q12) - EWSR1-ERG fusion
  • t(7;22)(p22;q12) - EWSR1-ETV1 fusion
The chimeric EWS/FLI1 protein binds chromatin and dysregulates transcription, driving uncontrolled proliferation and abnormal differentiation. The cell of origin is uncertain; mesenchymal stem cells and primitive neuroectodermal cells are the leading candidates. This is why Ewing sarcoma and Peripheral Primitive Neuroectodermal Tumors (PNETs) are now grouped under the Ewing Sarcoma Family of Tumors (ESFT).
  • Robbins & Kumar Basic Pathology, p. 786

Sites of Involvement

  • Long bones: Commonly originates in the metaphysis but typically extends extensively into the diaphysis; often a large portion or the entire bone is involved
  • Flat bones: Pelvis (most common flat bone), ribs, scapula
  • Spine: Primary vertebral Ewing sarcoma is rare (3.3-15%); sacrum involved in up to 50% of spinal cases
  • Common metastatic sites: Lungs (most common), then bone
X-rays and MRI of Ewing sarcoma of the fibula in a 7-year-old, showing periosteal reaction, soft tissue mass, and post-chemo response - Campbell's Operative Orthopaedics
Panels A/B: X-rays of the left fibula showing Ewing sarcoma involving a large portion of the bone. C: MRI showing large soft-tissue mass. D: Histology (small round blue cells). E/F: Post-neoadjuvant chemo X-rays showing increased ossification. G: MRI showing marked reduction in soft-tissue mass post-chemo. H/I: Post-wide resection radiographs.

Clinical Features

  • Pain - the most universal symptom; often insidious onset
  • Painful, tender, warm, erythematous, swollen mass - can mimic osteomyelitis (a classic mimicker)
  • Systemic symptoms: intermittent low-grade fever, leukocytosis, elevated ESR/CRP, anemia
  • A needle aspirate may resemble pus - always send biopsy specimens for both culture AND pathology
  • Average delay from symptom onset to diagnosis: 34 weeks (15 weeks patient delay + 19 weeks physician delay)
  • Campbell's Operative Orthopaedics 15th Ed 2026, p. 1222

Imaging

Plain Radiograph

  • Destructive, permeative ("moth-eaten") lytic lesion
  • Classic "onion-skin" periosteal reaction (multilayered periosteal bone deposition from the advancing tumor)
  • In flat bones: nonspecific destructive appearance

MRI

  • Gold standard for local staging; defines full extent of intramedullary and soft-tissue involvement (typically extends well beyond plain film abnormality)
  • Vertebral Ewing: isointense on T1, iso- to hyperintense on T2, intense gadolinium enhancement; "curtain sign" - invasion of spinal canal with paraspinal soft-tissue extension
  • Entire bone must be imaged

CT

  • Greater sensitivity than plain film for permeative destruction, especially in spine
  • CT chest mandatory (lungs = most common metastatic site)

Nuclear Medicine

  • Bone scan: bone is second most common metastatic site
  • FDG PET/CT: now the new standard for initial staging, detecting recurrence, and evaluating metastatic disease; high sensitivity and accuracy; initial SUV of primary tumor correlates with prognosis
  • Grainger & Allison's Diagnostic Radiology, p. 1285-1286
  • Campbell's Operative Orthopaedics 15th Ed 2026

Pathology / Histology

Gross: Soft, tan-white tumor arising in medullary cavity; frequently hemorrhagic and necrotic
Microscopy: Sheets of uniform small round cells (slightly larger and more cohesive than lymphocytes), scant cytoplasm that appears clear due to intracellular glycogen (PAS-positive), minimal intercellular matrix; does not produce bone or cartilage
  • Homer-Wright rosettes may be present (circular groupings of cells with central fibrillary core)
  • Geographic necrosis common
Ewing sarcoma histology - H&E showing sheets of small round blue cells with minimal clear cytoplasm - Robbins Pathology
Classic H&E appearance: sheets of small round blue cells with scant cytoplasm and round-to-oval nuclei - Robbins & Kumar Basic Pathology, Fig. 19.23

Differential Diagnosis of Small Round Blue Cell Tumors

The key differential for Ewing sarcoma includes:
TumorDistinguishing Feature
LymphomaPAS negative, reticulin positive; LCA, CD20/CD3 positive
NeuroblastomaUrinary catecholamines elevated; N-MYC amplification
RhabdomyosarcomaDesmin, myoglobin, muscle-specific actin positive
OsteosarcomaProduces osteoid matrix
Small cell carcinomaCytokeratin positive
Wilms tumorRenal location, WT1
DSRCTEWS-WT1 fusion t(11;22)(p13;q12); desmoplastic stroma

Immunohistochemistry for Ewing Sarcoma

  • CD99 (MIC-2 gene product): strong membranous positivity - most specific marker
  • PAS positive (intracellular glycogen)
  • Reticulin negative
  • EWSR1 rearrangement by FISH: confirmatory

Staging Workup

InvestigationPurpose
MRI of entire involved boneLocal staging, soft-tissue extent
CT chestPulmonary metastases (most common)
Bone scanBone metastases (2nd most common)
FDG PET/CTSystemic staging + baseline for response monitoring
Bone marrow aspirateRule out diffuse marrow involvement

Treatment

Ewing sarcoma is treated with a multimodal approach:

1. Neoadjuvant Chemotherapy (first)

Standard dose-intensive regimen: VDC/IE alternating cycles:
  • VDC: Vincristine + Doxorubicin + Cyclophosphamide
  • IE: Ifosfamide + Etoposide

2. Local Control (surgery and/or radiation)

  • Wide surgical resection is preferred for resectable tumors - avoids long-term complications of radiation (especially growth disturbance in children)
  • Radiation for unresectable tumors (e.g., large pelvic tumors), positive margins, or high-risk sites (spine)
  • After neoadjuvant chemo, repeat MRI typically shows marked reduction in soft-tissue mass and increased ossification on X-ray

3. Adjuvant Chemotherapy (consolidation)

Salvage Therapy (metastatic/recurrent disease)

  • Cyclophosphamide + Topotecan
  • Irinotecan + Temozolomide
  • Gemcitabine + Docetaxel
  • Goldman-Cecil Medicine, p. 1441-1443

Prognosis

Scenario5-Year Event-Free Survival
Localized disease (multiagent chemo)~70%
Clinically detectable metastatic diseasePoor
Adverse prognostic factors:
  • Large tumor volume
  • Pelvic/axial location
  • Presence of metastases at diagnosis
  • Poor histologic response to neoadjuvant chemotherapy
  • Elevated LDH

Key Memory Points

  1. t(11;22)(q24;q12) - EWSR1-FLI1 - present in >90%
  2. "Onion-skin" periosteal reaction - classic X-ray sign
  3. Small round blue cells + PAS positive (glycogen) + CD99 positive
  4. Diaphysis of long bones + flat bones (pelvis most common flat bone site)
  5. Mimics osteomyelitis clinically (fever, leukocytosis, warmth, swelling)
  6. Peak age: 10-20 years; rare in Black individuals
  7. Treatment: VDC/IE chemotherapy + surgery ± radiation
  8. Does NOT produce bone or cartilage (unlike osteosarcoma)

Sources: Robbins & Kumar Basic Pathology | Campbell's Operative Orthopaedics 15th Ed 2026 | Goldman-Cecil Medicine International Edition | Grainger & Allison's Diagnostic Radiology
This is a shared conversation. Sign in to Orris to start your own chat.